Financial News
All news about Sanofi-Aventis S.A.
2 Growth Stocks for In-the-Know Investors
February 03, 2021
From Motley Fool
Is It Too Late to Buy Pfizer Stock?
February 03, 2021
From Motley Fool
First Week of SNY February 19th Options Trading
February 02, 2021
Tags
Stocks
From Market News Video
What's the Upside for Novavax Stock?
February 02, 2021
From Motley Fool
A Preview Of The Busy Earnings Week Ahead
February 01, 2021
From Benzinga
From Benzinga
Is Vaxart Stock a Buy?
January 30, 2021
From Motley Fool
Breaking Down Novavax's Coronavirus Vaccine Data: 2 Analysts Takes
January 29, 2021
From Benzinga
First Week of SNY September 17th Options Trading
January 29, 2021
Tags
Stocks
From Market News Video
Why the No. 1 Healthcare Stock of 2020 Is Still a Buy
January 27, 2021
From Motley Fool
The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement
January 27, 2021
From Benzinga
From MarketWatch
From Benzinga
European stocks struggle and Nasdaq futures are higher with investors focused on Fed and big tech earnings
January 27, 2021
From MarketWatch
5 Value Stocks In The Healthcare Sector
January 25, 2021
From Benzinga
3 Reasons to Buy Novavax Stock, and 1 Reason to Sell
January 21, 2021
From Motley Fool
The Biggest Drug Competition in 2021 (Hint: It Isn't COVID Vaccines)
January 17, 2021
From Motley Fool
From Motley Fool
‘Manufacturers and middlemen have created a vicious cycle of price increases’: Mark Cuban pledges to sell this $225 medication for $20
January 15, 2021
From MarketWatch
Is Novavax's Growth Story Over?
January 15, 2021
From Motley Fool
Why Lexicon Pharmaceuticals Stock Doubled and Then Some on Thursday
January 14, 2021
From Motley Fool
Is Regeneron Stock Heading to $590?
January 13, 2021
From Motley Fool
Sanofi Spins Off an Industry-Leading Business
January 12, 2021
From Motley Fool
Biond Biologics and Sanofi Enter into Global Licensing Agreement for BND-22, a Novel Immune Checkpoint Inhibitor Targeting the ILT2 Receptor
January 12, 2021
From PR Newswire
3 Coronavirus Stocks to Stay Miles Away From in 2021
January 12, 2021
From Motley Fool
Up 1,530% in 2020, Is Vaxart Still a Buy?
January 08, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.